Biodesix_lockup_r_rgb (2).jpg
Biodesix Previews Data for Osimertinib Resistance and Precision of Liquid Biopsy at AACR
March 26, 2019 09:00 ET | Biodesix, Inc.
BOULDER, Colo., March 26, 2019 (GLOBE NEWSWIRE) -- Biodesix® will release new data demonstrating the potential diagnostic utility of a blood-based test for patients with resistance to osimertinib,...
Biodesix_lockup_r_rgb (2).jpg
Biodesix Test Predicts Response to Atezolizumab in Lung Cancer
November 12, 2018 09:00 ET | Biodesix, Inc.
Researchers Present New Data from Blood-Based Proteomic Test in Biomarkers and Immune Monitoring at SITC 2018   BOULDER, Colo. and WASHINGTON, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Researchers with...
Biodesix_lockup_r_rgb (2).jpg
Biodesix Advances ORACLE Registry for Lung Nodule Cancer Test
October 30, 2018 08:27 ET | Biodesix, Inc.
Noninvasive Test to Rule Out Cancer Expected to Lower Patient Anxiety and Costs BOULDER, Colo., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Biodesix® today provided an update on the Observational Registry...
Biodesix_lockup_r_rgb (2).jpg
Biodesix Presents Positive Data in Detection of Primary Immunotherapy Resistance to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer
October 22, 2018 03:00 ET | Biodesix, Inc.
Serum Proteomic Test Could Optimize Treatment by Identifying Patients Unlikely to Benefit from Immunotherapy BOULDER, Colo. and MUNICH, Germany, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Biodesix®...
Biodesix_lockup_r_rgb (2).jpg
Biodesix Pipeline Test Demonstrates Utility in Triaging Patients with Lung Nodules in New CHEST Data Publication
September 10, 2018 08:18 ET | Biodesix, Inc.
BOULDER, Colo., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Biodesix today announced newly published data showing the noninvasive BDX-XL2 test, currently in development, could reduce the number of...
Biodesix_lockup_r_rgb (2).jpg
Biodesix Confirms Prognostic Value of VeriStrat Testing in Phase 3 Study of Patients with Advanced Lung Cancer
August 29, 2018 08:21 ET | Biodesix, Inc.
BOULDER, Colo., Aug. 29, 2018 (GLOBE NEWSWIRE) -- A new study published in The Oncologist demonstrates the objective prognostic value of the Biodesix VeriStrat® test in patients with non-small cell...
Society for Advanced Bronchoscopy Commits to Enhance Education and Practice Excellence as U.S. Demand for Bronchoscopy Procedures Increases
May 29, 2018 12:22 ET | Biodesix, Inc.
TAMPA, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- Bronchoscopy professionals in the United States need greater educational and practice-building support to ensure continued delivery of high-quality care...
Society for Advanced Bronchoscopy Meets May 20 to Address “Hot Topics in Advanced Bronchoscopy”
May 15, 2018 09:21 ET | Biodesix, Inc.
TAMPA, Fla., May 15, 2018 (GLOBE NEWSWIRE) -- The Society for Advanced Bronchoscopy (SAB) will hold its second meeting, “Hot Topics in Advanced Bronchoscopy,” on Sunday, May 20th at the Hotel...
Biodesix_lockup_r_rgb (2).jpg
New Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment Decisions
April 30, 2018 09:20 ET | Biodesix, Inc.
- First Data Showing Prognostic Value of Test Among Patients by Performance Status Presented at ACMQ Annual Meeting –  - Optimizing Best Supportive Care and Avoiding Overtreatment Creates an Expected...
Biodesix_lockup_r_rgb (2).jpg
New Data Shows Biodesix Blood Test Reliably Detects Additional Mutations in Patients with NSCLC
April 18, 2018 09:00 ET | Biodesix, Inc.
BOULDER, Colo., April 18, 2018 (GLOBE NEWSWIRE) -- Biodesix®, Inc. is presenting new data today demonstrating the ability of the company’s droplet digital PCR (ddPCR™)-based platform to reliably...